Success Metrics

Clinical Success Rate
66.7%

Based on 6 completed trials

Completion Rate
67%(6/9)
Active Trials
8(40%)
Results Posted
0%(0 trials)
Terminated
3(15%)

Phase Distribution

Ph not_applicable
11
55%
Ph phase_3
4
20%
Ph phase_2
3
15%
Ph phase_4
1
5%

Phase Distribution

0

Early Stage

3

Mid Stage

5

Late Stage

Phase Distribution19 total trials
Phase 2Efficacy & side effects
3(15.8%)
Phase 3Large-scale testing
4(21.1%)
Phase 4Post-market surveillance
1(5.3%)
N/ANon-phased studies
11(57.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

6 of 9 finished

Non-Completion Rate

33.3%

3 ended early

Currently Active

8

trials recruiting

Total Trials

20

all time

Status Distribution
Active(9)
Completed(6)
Terminated(3)
Other(1)

Detailed Status

Recruiting7
Completed6
Terminated3
unknown1
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
8
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (15.8%)
Phase 34 (21.1%)
Phase 41 (5.3%)
N/A11 (57.9%)

Trials by Status

unknown15%
not_yet_recruiting15%
active_not_recruiting15%
completed632%
recruiting737%
terminated316%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT07573644Not Applicable

A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Brachial Access in the Endovascular Treatment of Peripheral Arterial Lesion

Not Yet Recruiting
NCT05581121Phase 3

PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer

Recruiting
NCT01507506Phase 3

Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma

Terminated
NCT06972719Not Applicable

Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy

Recruiting
NCT07381972Phase 3

Photodynamic Therapy Associated With Sonodynamic Therapy for the Treatment of Nodular Basal Cell Carcinoma

Recruiting
NCT07251088Not Applicable

Dyadic, App-supported Collaborative Care Intervention Trial for Family Caregivers of People Living With Dementia

Not Yet Recruiting
NCT04428554Phase 2

Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy

Recruiting
NCT03997435Phase 2

FOLFOXIRI With or Without Intensification for Rectal Cancer

Active Not Recruiting
NCT06222762Not Applicable

Effect of Personalized Follow-up in Adapted Physical Activities in Subjects With Chronic Heart Failure.

Recruiting
NCT02964858Not Applicable

Radiation Dose Optimization in Diffuse Large B- Cell Lymphoma.

Recruiting
NCT03788785Not Applicable

Smoking Tobacco Cessation Integrated Program of Patients Treated for the Head and the Neck Cancer

Completed
NCT04989725Phase 2

Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer

Recruiting
NCT04385433Phase 3

A Comparative Study of Pravastatin vs Placebo as Primary Prevention of Severe Subcutaneous Breast Fibrosis in Hyper-radiosensitive Identified Patients With Breast Cancer

Terminated
NCT02595281Not Applicable

HE4 as a Relapse Biomarker in Ovarian Cancers

Completed
NCT04298866Not Applicable

White Matter Hyperintensities Subtypes in Cerebral Small Vessel Disease : 7 Tesla Ultra-high Resolution Imaging MRI

Unknown
NCT01768156Not Applicable

Prognostic and Predictive Value of HE4 Biomarker in Metastatic Ovarian Cancer

Completed
NCT04266834Not Applicable

Establishing Clinical Utility of a New Diagnostic Test in Patients Undergoing Cardiac Catheterization

Completed
NCT04266821Not Applicable

Establishing Clinical Utility of a New Diagnostic Test for Patients Suffering From Pain: A CPV® Randomized Controlled Trial

Completed
NCT04204018Not Applicable

Measuring Practice Pattern Changes and Clinical Utility of a Novel Test for Preeclampsia

Completed
NCT01820078Phase 4

Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study)

Terminated

All 20 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
20